Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 3, 2012, Pages 877-884

  Yu, Dianke ^a   Shi, Juan ^b   Sun, Tong ^b   Du, Xiaoli ^b   Liu, L ^b   Zhang, Xiaojiao ^b   Lu, Chao ^b   Tang, Xiaohu ^b   Li, Meng ^b   Xiao, Lingchen ^b   Zhang, Zhouwei ^b   Yuan, Qipeng ^b   Yang, Ming ^b  

^a CANCER HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; PLATINUM;

ARTICLE; CANCER STAGING; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; META ANALYSIS; PATHOLOGY; PROGNOSIS; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DNA-BINDING PROTEINS; ENDONUCLEASES; GENETIC HETEROGENEITY; GENETIC VARIATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PLATINUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PUBLICATION BIAS; TREATMENT OUTCOME;

EID: 85027922301     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0314-y     Document Type: Article

References (0)